Discover Jewish-Owned Medical Marijuana Therapeutics

Since 2019, the women-owned, Jewish-owned practice Medical Marijuana Therapeutics has served as Georgia’s premier medical cannabis certification practice, helping Georgians with chronic health conditions access medical cannabis with safe, well-monitored, and successful outcomes.

Today, they serve around 500-600 patients, offering education, product recommendations, usage guidance, medication interactions, and customized treatment plans. Each patient is evaluated meticulously and carefully to ensure they receive the most comprehensive medical care possible. As much passion as the team possesses, it’s hard to believe that launching this business was never their plan until Melanie Jacobson firsthand experienced the medicinal and therapeutic benefits of medical cannabis.

Jacobson, who faced severe medical challenges growing up, said, “They [her family] had seen me struggle my entire childhood. When they saw how this [medical marijuana] affected me, it really didn’t take much to convince them that we should start this medical practice.”

Jacobson, along with her mother, Vicki Jacobson, and aunt, Madelaine Murad, M.D., came together, each bringing their own specialties to the table, to create Medical Marijuana Therapeutics (MMT). They understood on a personal level how vital it was to make medically-supported cannabis treatments accessible for others.

Dr. Murad, MMT’s chief medical officer, and Melanie Jacobson, MMT’s director of cannabis consulting, have both undergone extensive education to ensure they can provide the highest standard of care to all of their patients. Unlike other typical medical cannabis facilities, MMT does more than issuing medical marijuana cards. Vicki Jacobson, who serves as MMT’s chief operating and marketing officer, said, “We’re not just here to certify patients. We’re here to guide them through the process.”

Through a holistic approach that is fully compliant with Georgia law, MMT offers various services to their patients. The most comprehensive service one can receive is the Certification Package, which is most applicable for patients who do not yet have a Georgia medical marijuana card. After a prescreen to verify qualification, patients have a consultation with Dr. Murad, which includes an evaluation of needs, education, and assessment of medical conditions, medications, and possible interactions. Following the consultation, patients meet with Melanie Jacobson, who educates on the cannabis plant and discusses how it works to relieve symptoms and pain. After the two appointments, patients receive certification and entrance into the Department of Health Registry for their medical marijuana card. They are given a customized treatment plan, indicating which strains to use, which forms of treatment — varying from oils, capsules, lozenges, lotions and others, where to purchase them, and how to properly dose them.

The Non-Certification Package includes all the same services as the Certification Package but applies to patients who already have their medical marijuana card. If you live in Georgia and experience any of the following medical conditions, you would qualify for a medical marijuana card: Seizure Disorders, Multiple Sclerosis, Peripheral Neuropathy, Parkinson’s Disease, Alzheimer’s Disease, Tourette’s Syndrome, Amyotrophic Lateral Sclerosis, Autism Spectrum Disorder, Post-Traumatic Stress Disorder, Cancer, Mitochondrial Disease, Sickle Cell Disease, Crohn’s Disease, AIDS, Epidermolysis Bullosa, Intractable Pain, and In Hospice Program.

For patients who do not have a qualifying condition, they can still benefit from the Product Advisory service, which includes a session with Melanie Jacobson where patients receive education on how they can still benefit from non-THC cannabis and are given a personalized treatment plan. Through every service provided, Vicki Jacobson affirms MMT’s approach: “Everybody’s body chemistry is different. We’re trying to help them get to that sweet spot where they take just enough to get relief, but not so much that they feel uncomfortable [by experiencing psychoactivity].”

As many of the qualifying medical conditions affect seniors, MMT is extremely committed to spreading awareness about the benefits of medical cannabis and helping Georgia seniors safely access it. By offering step-by-step guidance, the practice helps patients navigate what can often be an overwhelming and uncertain process while providing the tools and support needed to make informed decisions about their care.

Medical marijuana acts as a natural alternative to a number of medications and can greatly reduce or replace the prescriptions people may be taking. When reflecting on the impact and medical cannabis journey of patients, specifically seniors,

Melanie Jacobson said, “A year later, we see them and they’re off several medications, and they’ve restored their quality of life.”

Furthermore, MMT is a solely virtual practice, offering telemedicine all across Georgia. Vicki Jacobson said, “People would drive a couple of hours to come see us. Now we can tell them, ‘You don’t have to leave your house. We can help you online.’”

Through telehealth, MMT is breaking barriers to access across the state and providing supportive care to a rising number of patients seeking alternative, organic treatments.

In addition to making a difference through MMT, Melanie Jacobson is very involved with the legislature regarding Georgia’s medical cannabis program. Working alongside State Rep. Long Tran of Georgia State House District 80, Melanie had the opportunity to draft House Bill 797 in 2023. This legislation later provided foundational language and messaging for the 2026 passage of the Putting Georgia’s Patients First Act, Senate Bill 220 (SB 220). Through the advocacy efforts of Melanie and numerous patient activists, SB 220 expands patient access to medical cannabis and moves Georgia closer to aligning its program with the 41 states that have established comprehensive medical cannabis programs.

The legislation officially replaces the term “low-THC oil” with “medical cannabis,” increases potency and possession limits, authorizes new delivery methods such as vaporization, and expands qualifying conditions to include lupus, severe arthritis, and severe insomnia. Additionally, SB 220 strengthens physician oversight and improves patient access throughout the certification and treatment process.

According to Vicki Jacobson, under the previous medical cannabis law, THC was limited to 5 percent by weight. Because the cap was based on weight, manufacturers could create products with varying potencies by adjusting the density of the product, as long as the THC content did not exceed 5 percent of the total weight. The new law removes the 5 percent potency limit, but it still restricts the THC to a specific amount. Instead of a percentage cap, it shifts to a milligram-based system, similar to the way pharmaceutical medications are measured. Under SB 220, THC content will be limited to 1,200 mg per individual product container.

When reflecting on her legislative advocacy, Melanie Jacobson expressed, “These barriers [of access] exist for my patients, and I have a way to change that.” The bill, SB 220, will be put into effect on July 1, but Melanie will continue to speak up until Georgia’s medical cannabis is as effective and accessible as possible.

In the field of medical marijuana practices across Georgia, MMT stands out for its commitment, guidance, knowledge, qualification, and support. This practice is an example of devoted people wanting to make a difference based on firsthand experience.

Vicki Jacobson said, “We observed her [Melanie] for so long not feeling well and then saw this metamorphosis. We thought, ‘Wow, we have to share this with the world.’”

Together, they created a practice that delivers real benefits for their patients and restores their quality of life. Melanie Jacobson said, “This is the biggest privilege of my life because I literally couldn’t get out of bed 18 hours a day. Now I can do anything I want.”

Through MMT, Melanie is able to give others the gift of relief that she herself experienced. With the support of her family, they are committed to championing this movement to significantly improve the wellbeing of so many Georgians dealing with qualifying diagnoses.

Visit mmtga.com or call or text 404-291-9103 to learn more or connect with the devoted team of Medical Marijuana Therapeutics.

A RESOLUTION

Recognizing and commending Medical Marijuana Therapeutics; and for other purposes.  

WHEREAS, Medical Marijuana Therapeutics (MMT) is a Georgia-founded, family-owned and operated medical cannabis practice led by a Georgia-licensed medical doctor and dedicated to improving the quality of life for patients across the State of Georgia; and  

WHEREAS, since 2019, MMT has distinguished itself as the gold standard in certification services through its patient-centered approach to cannabis-focused medical care, providing compassionate treatment, clinical professionalism, and ongoing support to individuals living with complex and chronic medical conditions; and  

WHEREAS, Dr. Madelaine Murad, the MMT Chief Medical Officer, has demonstrated a deep commitment to individualized patient care by thoroughly reviewing each patient’s medical history, medications, and prior treatment experiences in order to develop thoughtful cannabis treatment plans designed to support the best possible outcomes; and  

WHEREAS, Vicki Jacobson, Chief Operating Officer and Practice Director of MMT, has played an integral role in fostering a welcoming and supportive environment where patients feel understood, respected, and cared for while also leading community outreach efforts, particularly among seniors, to increase awareness of the medical cannabis program and its potential benefits; and  

WHEREAS, Melanie Jacobson, the MMT Cannabis Consultant, has combined patient advocacy, education, and personal understanding to help individuals throughout Georgia navigate medical cannabis treatment with compassion, confidence, and ongoing support aimed at improving quality of life; and  

WHEREAS, MMT hasprioritizedthedevelopmentoflong-termdoctor-patientrelationships grounded in trust, education, individualized care, and medical guidance tailored to each patient’s unique health needs; and  

WHEREAS, MMT’s medical doctor and cannabis consultant have been educated on and remain informed by the latest clinical cannabis research so they are well equipped to advise patients on cannabis products and provide comprehensive patient evaluations that include education on cannabis medicine and the endocannabinoid system, medication interaction reviews, guidance on products, formulations, delivery methods, and dosing, as well as customized treatment plans designed to improve quality of life while emphasizing safe, responsible, and therapeutic use; and  

WHEREAS, MMT has expanded access to medical cannabis education and care through statewide telemedicine services, helping patients throughout Georgia receive informed, compassionate, and medically supervised support regardless of geographic barriers; and  

WHEREAS, MMT has demonstrated a commitment to operating with integrity, professionalism, and compliance with Georgia law while also serving as a strong advocate for patient education, access, and continued improvements to Georgia’s Medical Cannabis Program; and  

WHEREAS, through its dedication to patient safety, medical education, ethical care standards, and responsible cannabis guidance, MMT has helped establish greater confidence and understanding surrounding medical cannabis treatment for patients and families across the State of Georgia.  

NOW, THEREFORE, BE IT RESOLVED BY THE HOUSE OF REPRESENTATIVES that the members of this body recognize and commend Medical Marijuana Therapeutics for its 45 many outstanding contributions on behalf of the citizens of this state and extend best wishes for continued success.  

BE IT FURTHER RESOLVED that the Clerk of the House of Representatives is authorized and directed to make an appropriate copy of this resolution available for distribution to Medical Marijuana Therapeutics.